James M. Thorburn - 03 Mar 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role: Chief Financial Officer
Signature: /s/ William Solis, as Attorney-in-Fact for James M. Thorburn
Issuer symbol: TWST
Transactions as of: 03 Mar 2022
Net transactions value: -$97,000
Form type: 4
Filing time: 07 Mar 2022, 15:35:26 UTC
Previous filing: 23 Feb 2022
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TWST	Common Stock	Options Exercise	$40,443	+1,517	+3.2%	$26.66	48,662	03 Mar 2022	Direct
transaction	TWST	Common Stock	Options Exercise	$46,660	+2,000	+4.1%	$23.33	50,662	03 Mar 2022	Direct
transaction	TWST	Common Stock	Sale	$109,489	-2,107	-4.2%	$51.96	48,555	03 Mar 2022	Direct	F1, F2
transaction	TWST	Common Stock	Sale	$64,951	-1,230	-2.5%	$52.81	47,325	03 Mar 2022	Direct	F1, F3
transaction	TWST	Common Stock	Sale	$9,662	-180	-0.38%	$53.68	47,145	03 Mar 2022	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TWST	Employee Stock Option (right to buy)	Options Exercise	$0	-1,517	-3.6%	$0.000000	40,381	03 Mar 2022	Common Stock	1,517	$26.66	Direct	F5
transaction	TWST	Employee Stock Option (right to buy)	Options Exercise	$0	-2,000	-7.2%	$0.000000	25,748	03 Mar 2022	Common Stock	2,000	$23.33	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
F2	Represents the weighted average sales price per share. The shares sold at prices ranging from $51.46 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3	Represents the weighted average sales price per share. The shares sold at prices ranging from $52.47 to $53.35 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4	Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)
F5	20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6	25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.